title: The impact of dual antiplatelet therapy duration on primary composite endpoint after drug-eluting stent implantation: A meta-analysis of 10 randomized trials.
authors.affiliation: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
authors.forename: Si
authors.initials: S
authors.lastname: Pang
authors.affiliation: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
authors.forename: Shun-Yi
authors.initials: SY
authors.lastname: Shi
authors.affiliation: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
authors.forename: Yao-Jun
authors.initials: YJ
authors.lastname: Zhang
authors.affiliation: Sheffield Teaching Hospitals and the University of Sheffield, Sheffield, United Kingdom.
authors.forename: Javaid
authors.initials: J
authors.lastname: Iqbal
authors.affiliation: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
authors.forename: Xiao-Yun
authors.initials: XY
authors.lastname: Chen
authors.affiliation: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
authors.forename: Xiao-Min
authors.initials: XM
authors.lastname: Ren
authors.affiliation: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
authors.forename: Hao
authors.initials: H
authors.lastname: Zhu
authors.affiliation: Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
authors.forename: Ya-Ping
authors.initials: YP
authors.lastname: Zeng
authors.affiliation: Department of Cardiology, University College London Hospital, London, United Kingdom.
authors.forename: Gabriel
authors.initials: G
authors.lastname: Bioh
authors.affiliation: Department of Cardiology, University College London Hospital, London, United Kingdom.
authors.forename: Christos V
authors.initials: CV
authors.lastname: Bourantas
authors.affiliation: Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Beijing 100037, China.
authors.forename: Bo
authors.initials: B
authors.lastname: Xu
authors.affiliation: International Centre for Circulatory Health, Imperial College London, London, United Kingdom.
authors.forename: Patrick W
authors.initials: PW
authors.lastname: Serruys
authors.affiliation: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: chmengx@126.com.
authors.forename: Shao-Liang
authors.initials: SL
authors.lastname: Chen
mesh_terms: D001241:Aspirin / Q000008:administration & dosage; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000188:drug therapy; D054855:Drug-Eluting Stents / Q000639:trends*; D023381:Endpoint Determination / Q000639:trends*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic / Q000379:methods*
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin
keywords: Drug-eluting stent; Dual antiplatelet therapy; Meta-analysis; Randomized controlled trials